Apple and OpenEvidence are launching a study based around an experimental AI-powered health chat app, hinting at possible new ...
The FDA has rejected ivonescimab, a treatment for a type of lung cancer developed by U.S. biotech Summit Therapeutics and the ...
Adam Feuerstein is a senior writer and biotech columnist, reporting on the crossroads of drug development, business, Wall Street, and biotechnology. He is also a co-host of the weekly biotech podcast ...
Senator-elect Abdul El-Sayed talks to STAT about restoring trust in science, the state of public health, and RFK Jr.
As researchers struggle to understand phone addiction, young people are finding ways to reclaim their attention and push back ...
New organ donation rules may “blur the line between the physicians fighting to save a patient's life and the teams ...
A STAT investigation of the fertility tourism industry found that clinics are offering an unproven IVF procedure to older ...
What people fear isn’t the end of life, the demise of the animated body, but the demise of the mind,” writes Jason Karlawish.
The Boston Globe investigates if Boston Scientific's marketing of its cardiac implant, Watchman, outpaced the science.
WASHINGTON — Democrats are coalescing around a plan to offer Medicare to more Americans, if not all of them. As the party ...
Enforcement of the Trump administration's stringent new Medicaid work requirements have delayed for six months, until July 1, ...
On day one, governors should know kindergarten vaccination rates by county,” write Mandy Cohen and Ellen Montz.